Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
We provide 1 form of Tucatinib
Tucatinib
937263-43-9
|
480.202
|
5.315
Tucatinbib is a kinase inhibitor drug used with trastuzumab and capecitabine in the treatment of unresectable or metastatic HER-2 positive breast cancer. It is a promising new treatment for patients with metastatic breast cancer who have not responded adequately to other chemotherapy regimens.
ARRY-380 | ONT-380 | irbinitinib | tucatinib
Tucatinbib is a kinase inhibitor drug used with trastuzumab and capecitabine in the treatment of unresectable or metastatic HER-2 positive breast cancer. It is a promising new treatment for patients with metastatic breast cancer who have not responded adequately to other chemotherapy regimens.
ARRY-380 | ONT-380 | irbinitinib | tucatinib
$55/5 mg
(EBC)
1
We provide 0 compound for Tucatinib
